sQuiz editorial: Latent tuberculosis infection: Update of diagnosis before the introduction of biologic drugs

WHO Online Tuberculosis Database. www.who.int/tb/country/ data/profiles.(Accesed 21.07.15). García-Casalla Payeras-Cifre A, Cifuentes-Luna C, Taberner-Ferrer R, et al. Use of Quantiferon-TB-Gold in Tube® test for detecting latent tuberculosis in patients considered as candidates for anti-TNF therapy in routine clinical practice. Enferm Infecc Microbiol Clin 2013; 31: 76–81. Gisondi P, Pezzolo E, Lo Cascio G, Girolomoni G. Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy. Br J Dermatol 2014; 171: 884–90. Hewitt RJ, Francis M, Singanayagam A, Min Kon O. Screening tests for tuberculosis before starting biological therapy. Br Med J 2015; 350: h1060. Latorre I, Carrascosa JM, Vilavella M, et al. Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis. J Infect 2014; 69: 600–6. Mir Viladrich I, Daudén Tello E, Solano-López G, et al. Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment. Arch Bronconeumol 2016; 52: 36–45.